Home / Current Issue / Paper 1719514
Antimicrobial Resistance and Antimicrobial Stewardship in Community and Hospital Pharmacy Practice: A Scoping Review
Subject area: Biological & Medical Sciences · Area of research: Pharmacy
Abstract
Background: Pharmacists in the community and hospital are becoming more and more involved in antimicrobial stewardship (AMS) and antimicrobial resistance (AMR) increases the disease burden, affects all countries, and is one of the most severe global public health problems. However, the extent of the roles, interventions and reported outcomes of the pharmacist varies throughout the various settings of care and has not been consistently mapped. Objective: To summarise and interpret up to date evidence of the use of AMR and AMS in community and hospital practice, summarise the nature of intervention by a pharmacist, the determinants of satisfaction with AMS and AMR implementation including factors related to the clinical, behavioural and organisational outcomes reported. Methods: Peer-reviewed literature until 2024 was mapped according to a PRISMA-ScR flow diagram, guided by a scoping framework developed by Arksey and O’Malley. Twenty sources from high-, middle- and low-income settings were identified, mapped by setting and by type of intervention, and further by outcome domain. Results: The interventions for AMS were grouped into four categories: educational, persuasive, restrictive and structural. The interventions at hospitals were most successful overall in reducing antimicrobial use and antimicrobial treatment duration without impacting safety, while community interventions resulted in better appropriate dispensing, public awareness, and referring practices; interventions at discharge were inconsistent. Hospital interventions were most successful in reducing antimicrobial use and duration of treatment without compromising safety, while community interventions were effective in improving appropriate dispensing, public awareness, and referral; interventions at discharge were inconsistent. Determinants of implementation which were consistent across all clusters were knowledge gaps, remuneration, regulatory ambiguity and interprofessional trust. Conclusion: Evidence supporting pharmacists' role in strengthen stewardship along the care continuum exists, however is fragmented and biased toward high income hospital settings. To ensure AMR is managed and controlled as a consequence of its contribution to the practice, standardisation of reporting of outcomes, sustainable funding and increased scope of practice frameworks are required.
Keywords
Antimicrobial Resistance, Antimicrobial Stewardship, Community Pharmacy, Hospital Pharmacy, Pharmacist-Led Interventions, Scoping Review
References
[1] Antimicrobial Resistance Collaborators. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
[2] Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A.,
[3] Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., Hamilton, C. W., Jenkins, T. C., Lipsett, P. A., Malani, P. N., May, L. S., Moran, G. J., Neuhauser, M. M., Newland, J. G., Ohl, C. A., … Trivedi, K. K. (2016). Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, 62(10), e51–e77. https://doi.org/10.1093/cid/ciw118
[4] Dighriri, I. M., Alnomci, B. A., Aljahdali, M. M., Althagafi, H. S., Almatrafi, R. M., Altwairqi, W. G., Almagati, A. A., Shunaymir, A. M., Haidarah, G. A., Alanzi, M. H., Hadadi, A. A., Suwaydi, H. M., Aqdi, M. J., Alharthi, H. N., & Alshahrani, A. F. (2023). The role of clinical pharmacists in antimicrobial stewardship programs (ASPs): A systematic review. Cureus, 15(12), e50151. https://doi.org/10.7759/cureus.50151
[5] Garau, J., & Bassetti, M. (2018). Role of pharmacists in antimicrobial stewardship programmes. International Journal of Clinical Pharmacy, 40(5), 948–952. https://doi.org/10.1007/s11096-018-0675-z
[6] GBD 2021 Antimicrobial Resistance Collaborators. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. The Lancet, 404(10459), 1199–1226. https://doi.org/10.1016/S0140-6736(24)01867-1
[7] Hayes, C. V., Parekh, S., Lecky, D. M., Loader, J., Triggs-Hodge, C., & Ashiru-Oredope, D. (2023). The national implementation of a community pharmacy antimicrobial stewardship intervention (PAMSI) through the English Pharmacy Quality Scheme 2020 to 2022. Antibiotics, 12(4), 793. https://doi.org/10.3390/antibiotics12040793
[8] Khan, M. U., Hassali, M. A. A., Ahmad, A., Elkalmi, R. M., Zaidi, S. T. R., & Dhingra, S. (2016). Perceptions and practices of community pharmacists towards antimicrobial stewardship in the state of Selangor, Malaysia. PLoS ONE, 11(2), e0149623. https://doi.org/10.1371/journal.pone.0149623
[9] Kooda, K., Canterbury, E., & Bellolio, F. (2022). Impact of pharmacist-led antimicrobial stewardship on appropriate antibiotic prescribing in the emergency department: A systematic review and meta-analysis. Annals of Emergency Medicine, 79(4), 374–387. https://doi.org/10.1016/j.annemergmed.2021.11.031
[10] Monmaturapoj, T., Scott, J., Smith, P., Abutheraa, N., & Watson, M. C. (2021). Pharmacist-led education-based antimicrobial stewardship interventions and their effect on antimicrobial use in hospital inpatients: A systematic review and narrative synthesis. Journal of Hospital Infection, 115, 93–116. https://doi.org/10.1016/j.jhin.2021.06.003
[11] Otieno, P. A., Campbell, S., Maley, S., Obinju Arunga, T., & Otieno Okumu, M. (2022). A systematic review of pharmacist-led antimicrobial stewardship programs in sub-Saharan Africa. International Journal of Clinical Practice, 2022, Article 3639943. https://doi.org/10.1155/2022/3639943
[12] Rizvi, T., Thompson, A., Williams, M., & Zaidi, S. T. R. (2018). Perceptions and current practices of community pharmacists regarding antimicrobial stewardship in Tasmania. International Journal of Clinical Pharmacy, 40(5), 1380–1387. https://doi.org/10.1007/s11096-018-0701-1
[13] Saha, S. K., Barton, C., Promite, S., & Mazza, D. (2019a). Knowledge, perceptions and practices of community pharmacists towards antimicrobial stewardship: A systematic scoping review. Antibiotics, 8(4), 263. https://doi.org/10.3390/antibiotics8040263
[14] Saha, S. K., Hawes, L., & Mazza, D. (2019b). Effectiveness of interventions involving pharmacists on antibiotic prescribing by general practitioners: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy, 74(5), 1173–1181. https://doi.org/10.1093/jac/dky572
[15] Saha, S. K., Kong, D. C. M., Thursky, K., & Mazza, D. (2021). Antimicrobial stewardship by Australian community pharmacists: Uptake, collaboration, challenges, and needs. Journal of the American Pharmacists Association, 61(2), 158–168.e7. https://doi.org/10.1016/j.japh.2020.10.014
[16] Sakeena, M. H. F., Bennett, A. A., & McLachlan, A. J. (2018). Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: A narrative review. Antimicrobial Resistance & Infection Control, 7, Article 63. https://doi.org/10.1186/s13756-018-0351-z
[17] Saleh, D., Abu Farha, R., Mukattash, T. L., Barakat, M., & Alefishat, E. (2021). Views of community pharmacists on antimicrobial resistance and antimicrobial stewardship in Jordan: A qualitative study. Antibiotics, 10(4), 384. https://doi.org/10.3390/antibiotics10040384
[18] Sarwar, M. R., Saqib, A., Iftikhar, S., & Sadiq, T. (2018). Knowledge of community pharmacists about antibiotics, and their perceptions and practices regarding antimicrobial stewardship: A cross-sectional study in Punjab, Pakistan. Infection and Drug Resistance, 11, 133–145. https://doi.org/10.2147/IDR.S148102
[19] St. Louis, J., & Okere, A. N. (2021). Clinical impact of pharmacist-led antibiotic stewardship programs in outpatient settings in the United States: A scoping review. American Journal of Health-System Pharmacy, 78(15), 1426–1437. https://doi.org/10.1093/ajhp/zxab178
[20] Tonna, A. P., Weidmann, A. E., Sneddon, J., & Stewart, D. (2020). Views and experiences of community pharmacy team members on antimicrobial stewardship activities in Scotland: A qualitative study. International Journal of Clinical Pharmacy, 42(5), 1261–1269. https://doi.org/10.1007/s11096-020-01042-z
[21] World Health Organization. (2015). Global action plan on antimicrobial resistance. World Health Organization. https://www.who.int/publications/i/item/9789241509763
How to cite this paper
@article{1719514,
author = {Harry S Patel},
title = {Antimicrobial Resistance and Antimicrobial Stewardship in Community and Hospital Pharmacy Practice: A Scoping Review},
journal = {Iconic Research And Engineering Journals},
year = {2025},
volume = {8},
number = {9},
pages = {2050-2064},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1719514.pdf},
abstract = {Background: Pharmacists in the community and hospital are becoming more and more involved in antimicrobial stewardship (AMS) and antimicrobial resistance (AMR) increases the disease burden, affects all countries, and is one of the most severe global public health problems. However, the extent of the roles, interventions and reported outcomes of the pharmacist varies throughout the various settings of care and has not been consistently mapped.
Objective: To summarise and interpret up to date evidence of the use of AMR and AMS in community and hospital practice, summarise the nature of intervention by a pharmacist, the determinants of satisfaction with AMS and AMR implementation including factors related to the clinical, behavioural and organisational outcomes reported.
Methods: Peer-reviewed literature until 2024 was mapped according to a PRISMA-ScR flow diagram, guided by a scoping framework developed by Arksey and O’Malley. Twenty sources from high-, middle- and low-income settings were identified, mapped by setting and by type of intervention, and further by outcome domain.
Results: The interventions for AMS were grouped into four categories: educational, persuasive, restrictive and structural. The interventions at hospitals were most successful overall in reducing antimicrobial use and antimicrobial treatment duration without impacting safety, while community interventions resulted in better appropriate dispensing, public awareness, and referring practices; interventions at discharge were inconsistent. Hospital interventions were most successful in reducing antimicrobial use and duration of treatment without compromising safety, while community interventions were effective in improving appropriate dispensing, public awareness, and referral; interventions at discharge were inconsistent. Determinants of implementation which were consistent across all clusters were knowledge gaps, remuneration, regulatory ambiguity and interprofessional trust.
Conclusion: Evidence supporting pharmacists' role in strengthen stewardship along the care continuum exists, however is fragmented and biased toward high income hospital settings. To ensure AMR is managed and controlled as a consequence of its contribution to the practice, standardisation of reporting of outcomes, sustainable funding and increased scope of practice frameworks are required.},
keywords = {Antimicrobial Resistance, Antimicrobial Stewardship, Community Pharmacy, Hospital Pharmacy, Pharmacist-Led Interventions, Scoping Review},
month = {March},
doi = {https://doi.org/10.64388/IREV8I9-1719514}
}